EN
- Bifidobacterium breve CCFM1026
- Lactobacillus reuteri CCFM1072
- Lactobacillus casei CCFM1059
- Lactobacillus plantarum CCFM8610
- Lactobacillus acidophilus L59
- 1) Immune-focused probiotic formula, helps regulate immune responses
- 2) Helps reduce immune hypersensitivity related to allergy-like symptoms
- 3) Supports respiratory and gut immune balance
- 4) Enhances overall immune tolerance and daily immune resilience
HelpAller™ Immunity Health - Regulate Immunity
Formulation
Functionality
Scientific Support
Human clinical trial
1) Liu Y, Yu X, Yu L, Tian F, Zhao J, Zhang H, Qian L, Wang Q, Xue Z, Zhai Q, Chen W. Lactobacillus plantarum CCFM8610 alleviates irritable bowel syndrome and prevents gut microbiota dysbiosis: a randomized, double‑blind, placebo‑controlled, pilot clinical trial. Engineering. 2021;7(3):376–385. doi:10.1016/j.eng.2020.06.026. PMID: not available.
2) Zhang H, Tian P, Chen Y, Wang L, Qian L, Zhao J, Wang Q, Chen W. Lactobacillus reuteri CCFM1072 and CCFM1040 alleviate airway inflammation through modulating gut microbiota in allergic asthma mice. Curr Opin Food Sci. 2020;36:43-52. doi:10.1016/j.cofs.2020.07.007.
3) Fang Z, Lu W, Zhao J, Zhang H, Qian L, Wang Q, Chen W. Probiotics modulate the gut microbiota composition and immune responses in patients with atopic dermatitis: a pilot study. Eur J Nutr. 2020;59(5):2119-2130. doi:10.1007/s00394-019-02061-x.
Pre-clinical paper
1) Lu W, Fang Z, Liu X, Li L, Zhang P, Zhao J, Zhang H, Chen W. The potential role of probiotics in protection against influenza A virus infection in mice. Foods. 2021;10(4):902. doi:10.3390/foods10040902. PMID: 33924002. PMCID: PMC8073107.
Patent
1) Jiangnan University, A Bifidobacterium breve strain with anti-influenza and immune-modulating activity. Chinese Invention Patent, Granted Publication Number CN110055185A.
2) Jiangnan University, A Lactobacillus reuteri strain capable of relieving allergic asthma-related Th2 immune responses. Chinese Invention Patent, Granted Publication Number CN110643542B.
3) Jiangnan University, A Lactobacillus casei strain that increases intestinal IL-22 expression and supports intestinal immune health. Chinese Invention Patent, Granted Publication Number CN110591950B.
4) Jiangnan University, A Lactobacillus plantarum strain that reduces intestinal IL-17F expression and modulates inflammatory immune responses. Chinese Invention Patent, Granted Publication Number CN110680837A.